[1]
M. Sarfaraz, T. Goel, and H. Doddayya, “Formulation and Evaluation of Galantamine Hydrobromide Proniosome Gel for Alzheimer’s disease”, J. Drug Delivery Ther., vol. 10, no. 2-s, pp. 68–74, Apr. 2020, doi: 10.22270/jddt.v10i2-s.4027.